sábado, 20 de agosto de 2022

Protein-based vaccine as the booster dose for adults: evidence and beyond - The Lancet Infectious Diseases

Protein-based vaccine as the booster dose for adults: evidence and beyond - The Lancet Infectious Diseases

No hay comentarios:

Publicar un comentario